Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds RJ Scott, M McPhillips, CJ Meldrum, PE Fitzgerald, K Adams, ... The American Journal of Human Genetics 68 (1), 118-127, 2001 | 255 | 2001 |
CARD15/NOD2 Risk Alleles in the Development of Crohn's Disease in the Australian Population JA Cavanaugh, KE Adams, EJ Quak, ME Bryce, NJ O'Callaghan, ... Annals of human genetics 67 (1), 35-41, 2003 | 110 | 2003 |
A comprehensive investigation of variants in genes encoding adiponectin (ADIPOQ) and its receptors (ADIPOR1/R2), and their association with serum adiponectin … KE Peters, J Beilby, G Cadby, NM Warrington, DG Bruce, WA Davis, ... BMC Medical Genetics 14, 1-12, 2013 | 109 | 2013 |
Effect of continuous positive airway pressure therapy on cardiovascular risk factors in patients with type 2 diabetes and obstructive sleep apnea PC Myhill, WA Davis, KE Peters, SAP Chubb, D Hillman, TME Davis The Journal of Clinical Endocrinology & Metabolism 97 (11), 4212-4218, 2012 | 101 | 2012 |
Fear of falling is common in patients with type 2 diabetes and is associated with increased risk of falls D Bruce, M Hunter, K Peters, T Davis, W Davis Age and ageing 44 (4), 687-690, 2015 | 84 | 2015 |
The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study KE Peters, SAP Chubb, WA Davis, TME Davis PloS one 8 (9), e74355, 2013 | 83 | 2013 |
Identification of novel circulating biomarkers predicting rapid decline in renal function in type 2 diabetes: the Fremantle diabetes study phase II KE Peters, WA Davis, J Ito, K Winfield, T Stoll, SD Bringans, ... Diabetes Care 40 (11), 1548-1555, 2017 | 72 | 2017 |
Prevalence of diabetes in Australia: insights from the Fremantle Diabetes Study Phase II WA Davis, KE Peters, A Makepeace, S Griffiths, C Bundell, SFA Grant, ... Internal medicine journal 48 (7), 803-809, 2018 | 57 | 2018 |
Polymorphisms associated with normal memory variation also affect memory impairment in schizophrenia A Jablensky, B Morar, S Wiltshire, K Carter, M Dragovic, JC Badcock, ... Genes, brain and behavior 10 (4), 410-417, 2011 | 55 | 2011 |
Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes K Peters, S Wiltshire, AK Henders, M Dragović, JC Badcock, D Chandler, ... American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 147 …, 2008 | 42 | 2008 |
Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea A Knapp, PC Myhill, WA Davis, KE Peters, D Hillman, EJ Hamilton, ... Clinical endocrinology 81 (2), 254-258, 2014 | 37 | 2014 |
Comprehensive mass spectrometry based biomarker discovery and validation platform as applied to diabetic kidney disease SD Bringans, J Ito, T Stoll, K Winfield, M Phillips, K Peters, WA Davis, ... EuPA Open Proteomics 14, 1-10, 2017 | 30 | 2017 |
Lifetime depression history and depression risk in type 2 diabetes: A case-control study DG Bruce, WA Davis, ML Hunter, KE Peters, TME Davis, SE Starkstein Journal of Diabetes and its Complications 30 (1), 38-42, 2016 | 30 | 2016 |
Prevalence, incidence, and prognosis of hepatobiliary disease in community-based patients with type 2 diabetes: the Fremantle Diabetes Study TME Davis, KE Peters, DG Bruce, WA Davis The Journal of Clinical Endocrinology 97 (5), 1581-1588, 2012 | 25 | 2012 |
The prevalence of monogenic diabetes in Australia: the Fremantle Diabetes Study Phase II TME Davis, AE Makepeace, S Ellard, K Colclough, K Peters, A Hattersley, ... Medical Journal of Australia 207 (8), 344-347, 2017 | 24 | 2017 |
Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study SA Paul Chubb, WA Davis, KE Peters, TME Davis Cardiovascular diabetology 15, 1-10, 2016 | 22 | 2016 |
Prevalence and prognosis of a low serum testosterone in men with type 2 diabetes: the Fremantle Diabetes Study Phase II EJ Hamilton, WA Davis, A Makepeace, EM Lim, BB Yeap, KE Peters, ... Clinical Endocrinology 85 (3), 444-452, 2016 | 22 | 2016 |
Prevalence and incidence of thyroid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: the Fremantle Diabetes Study Phase II KE Peters, SAP Chubb, DG Bruce, WA Davis, TME Davis Clinical endocrinology 92 (4), 373-382, 2020 | 20 | 2020 |
Lack of association of the CD14 promoter polymorphism −159C/T with Caucasian inflammatory bowel disease KE Peters, NJ O'Callaghan, JA Cavanaugh Scandinavian journal of gastroenterology 40 (2), 194-197, 2005 | 18 | 2005 |
Analysis by proteomics reveals unique circulatory proteins in idiopathic pulmonary fibrosis YP Moodley, TJ Corte, BG Oliver, IN Glaspole, A Livk, J Ito, K Peters, ... Respirology 24 (11), 1111-1114, 2019 | 17 | 2019 |